GWS
PTCT icon

Glassman Wealth Services’s PTC Therapeutics PTCT Stock Holding History

Glassman Wealth Services’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5
Closed – – 1934
2022
Q1 		$0 Hold
5
– – ﹤0.01% 1886
2021
Q4 		$0 Sell
5
-13
-72% -$498 ﹤0.01% 1852
2021
Q3 		$1K Buy
18
+5
+38% +$205 ﹤0.01% 1436
2021
Q2 		$1K Buy
13
+5
+63% +$214 ﹤0.01% 1359
2021
Q1 		$0 Buy
8
+3
+60% +$178 ﹤0.01% 1588
2020
Q4 		$0 Hold
5
– – ﹤0.01% 1487
2020
Q3 		$0 Hold
5
– – ﹤0.01% 1466
2020
Q2 		$0 Hold
5
– – ﹤0.01% 1471
2020
Q1 		$0 Buy
+5
New +$252 ﹤0.01% 1472
2019
Q4 		– Sell
-5
Closed – – 1417
2019
Q3 		$0 Hold
5
– – ﹤0.01% 1309
2019
Q2 		$0 Buy
+5
New +$197 ﹤0.01% 1306

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Glassman Wealth Services's PTCT Position: Q2 2022 in Review

Glassman Wealth Services sold out of PTC Therapeutics (PTCT) in Q2 2022, closing a stake of 5 shares.

Glassman Wealth Services first reported a position in PTCT in Q2 2019 and held it in 11 quarters. The position peaked at $1K in Q3 2021. 180 funds tracked by Wall St. Rank hold PTCT as of Q2 2022.

  • Glassman Wealth Services reported no remaining PTC Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Glassman Wealth Services sold 5 PTC Therapeutics shares in Q2 2022.
  • Glassman Wealth Services first reported a position in PTC Therapeutics in Q2 2019 and held it in 11 quarters.
  • Glassman Wealth Services's PTC Therapeutics position peaked at $1K in Q3 2021.
  • 180 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2022.

Based on Glassman Wealth Services's 13F filing for Q2 2022, filed 4 Aug 2022.